BIOMAT Database Logo BIOMAT Database Logo

[Intestinal mode of action of Saccharomyces boulardii]. 1986

P Chapoy

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007583 Jejunum The middle portion of the SMALL INTESTINE, between DUODENUM and ILEUM. It represents about 2/5 of the remaining portion of the small intestine below duodenum. Jejunums
D008854 Microscopy, Electron Microscopy using an electron beam, instead of light, to visualize the sample, thereby allowing much greater magnification. The interactions of ELECTRONS with specimens are used to provide information about the fine structure of that specimen. In TRANSMISSION ELECTRON MICROSCOPY the reactions of the electrons that are transmitted through the specimen are imaged. In SCANNING ELECTRON MICROSCOPY an electron beam falls at a non-normal angle on the specimen and the image is derived from the reactions occurring above the plane of the specimen. Electron Microscopy
D002448 Cell Adhesion Adherence of cells to surfaces or to other cells. Adhesion, Cell,Adhesions, Cell,Cell Adhesions
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012440 Saccharomyces A genus of ascomycetous fungi of the family Saccharomycetaceae, order SACCHAROMYCETALES. Saccharomyce

Related Publications

P Chapoy
Effects of Saccharomyces boulardii on intestinal mucosa.
August 2006, Digestive diseases and sciences,
P Chapoy
Diversity of Saccharomyces boulardii CNCM I-745 mechanisms of action against intestinal infections.
May 2019, World journal of gastroenterology,
P Chapoy
Review article: anti-inflammatory mechanisms of action of Saccharomyces boulardii.
October 2009, Alimentary pharmacology & therapeutics,
P Chapoy
[Intestine-associated immune system stimulation. Saccharomyces boulardii--mechanism of action].
October 1994, Fortschritte der Medizin,
P Chapoy
Increased intestinal delivery of viable Saccharomyces boulardii by encapsulation in microspheres.
June 2008, Pharmaceutical research,
P Chapoy
[Modifying action of Saccharomyces boulardii on the biological properties of enterobacteria].
January 2002, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
P Chapoy
Saccharomyces boulardii in Crohn's disease: effect on anti-Saccharomyces cerevisiae antibodies and intestinal permeability.
September 2005, Inflammatory bowel diseases,
P Chapoy
Saccharomyces boulardii is not Saccharomyces cerevisiae.
January 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
P Chapoy
The probiotic Saccharomyces boulardii upgrades intestinal digestive functions by several mechanisms.
January 2009, Acta gastro-enterologica Belgica,
P Chapoy
Saccharomyces boulardii in childhood.
March 2009, European journal of pediatrics,
Copied contents to your clipboard!